Research shows that miR-499a inhibits prostate cancer proliferation by targeting UBE2V2.27 Wang et al28 found that miR-499a slows glioma cell proliferation by suppressing Notch1 and MAPK signaling. Here, UBE2V2 is linked to prostate carcinoma.